Literature DB >> 3967834

Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.

C Hendriksen, S Kreiner, V Binder.   

Abstract

The prognosis of ulcerative colitis including survival, colectomy rate, activity of disease, and working capacity was estimated from a follow up study of 783 patients with ulcerative colitis comprising all patients from the county of Copenhagen, except for the island of Amager, diagnosed between 1960 and 1978. The period of observation ranged from one to 18 years with a median of 6.7 years for the clinical observations, eight years for survival and 11.6 years for the occurrence of large bowel cancer. The follow up was 100% for both survival and cancer. The survival rate in women did not differ from that in the general population. In men over 40 years of age at diagnosis a slight excess mortality was found, but only in the year of diagnosis (2.1%) and the following year (1.5%). Colonic cancer was seen in only seven out of the 783 patients, corresponding to an annual risk of 0.07% and a cumulative risk after 18 years with ulcerative colitis of 1.4% (95% confidence limits, 0.7-2.8%) independent of the initial extent of disease. The colectomy rate was 9.6% in the year of diagnosis. The cumulative 10- and 18-year colectomy rate was 23% and 31%, respectively. After three years from diagnosis the capacity for work both in those subject to resection and treated conservatively did not differ significantly from that in the background population. At any time about 50% of the patients were without symptoms, in about 30% the disease activity was low and in about 20% moderate or high. Most patients, however, differed in activity from one year to another and almost all patients (97%) experienced at least one relapse during a 10 year time period.

Entities:  

Mesh:

Year:  1985        PMID: 3967834      PMCID: PMC1432417          DOI: 10.1136/gut.26.2.158

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Survival rate in Crohn's disease and ulcerative colitis.

Authors:  L Storgaard; N Bischoff; F W Henriksen; K Fischerman; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

2.  The prognosis of ulcerative colitis.

Authors:  O Bonnevie; V Binder; P Anthonisen; P Riis
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

3.  Clinical course of ulcerative colitis in Italy.

Authors:  G A Lanfranchi; C Brignola; M Michelini; M Campieri; G Bazzocchi; A Benatti; C Cortini; G Labó; A Parmeggiani
Journal:  Digestion       Date:  1980       Impact factor: 3.216

4.  Clinical outcome of the first ten years of ulcerative colitis and proctitis.

Authors:  J K Ritchie; J Powell-Tuck; J E Lennard-Jones
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

5.  Social prognosis in patients with ulcerative colitis.

Authors:  C Hendriksen; V Binder
Journal:  Br Med J       Date:  1980-08-30

6.  Ulcerative colitis in the Jewish population of Tel-Aviv Yafo. III. Clinical course.

Authors:  T Gilat; P Lilos; Z Zemishlany; J Ribak; Y Benaroya
Journal:  Gastroenterology       Date:  1976-01       Impact factor: 22.682

7.  Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group.

Authors:  H Both; K Torp-Pedersen; S Kreiner; C Hendriksen; V Binder
Journal:  Scand J Gastroenterol       Date:  1983-10       Impact factor: 2.423

8.  Nonspecific proctocolitis in northeastern Scotland: a community study.

Authors:  T S Sinclair; P W Brunt; N A Mowat
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

9.  Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978.

Authors:  V Binder; H Both; P K Hansen; C Hendriksen; S Kreiner; K Torp-Pedersen
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

10.  Mortality in ulcerative colitis.

Authors:  S Gyde; P Prior; M J Dew; V Saunders; J A Waterhouse; R N Allan
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

View more
  60 in total

1.  Prediction of short-term outcome for patients with active ulcerative colitis.

Authors:  N Oshitani; T Matsumoto; Y Jinno; Y Sawa; J Hara; S Nakamura; T Arakawa; A Kitano; T Kuroki
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

Review 2.  Ulcerative colitis.

Authors:  S Ghosh; A Shand; A Ferguson
Journal:  BMJ       Date:  2000-04-22

Review 3.  Current concept of pathophysiological understanding and natural course of ulcerative colitis.

Authors:  Martin H Holtmann; Peter R Galle
Journal:  Langenbecks Arch Surg       Date:  2004-02-04       Impact factor: 3.445

4.  Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.

Authors:  Wei Gong; Nonghua Lv; Bangmao Wang; Ye Chen; Yinglong Huang; Wenshen Pan; Bo Jiang
Journal:  Dig Dis Sci       Date:  2011-09-22       Impact factor: 3.199

5.  Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.

Authors:  Eun Soo Kim; Won Ho Kim
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 6.  Recent epidemiology of ulcerative colitis and Crohn's disease.

Authors:  J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 7.  Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass.

Authors:  J B Fozard; M F Dixon
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

Review 8.  Infection, inflammation, and gastrointestinal cancer.

Authors:  C R Boland; M G Luciani; C Gasche; A Goel
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

9.  Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis.

Authors:  Meenakshi Bewtra; Lisa M Kaiser; Tom TenHave; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

10.  Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  Harry Sokol; Jacques Cosnes; Olivier Chazouilleres; Laurent Beaugerie; Emmanuel Tiret; Raoul Poupon; Philippe Seksik
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.